Obermeyer Wealth Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Obermeyer Wealth Partners’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-65	Closed	-$8K	–	130
2019 Q2	$8K	Hold	65	–	–	﹤0.01%	118
2019 Q1	$11K	Hold	65	–	–	﹤0.01%	113
2018 Q4	$8K	Hold	65	–	–	﹤0.01%	110
2018 Q3	$10K	Hold	65	–	–	﹤0.01%	119
2018 Q2	$43K	Hold	65	–	–	﹤0.01%	115
2018 Q1	$66K	Hold	65	–	–	0.01%	111
2017 Q4	$79K	Hold	65	–	–	0.01%	120
2017 Q3	$12K	Hold	65	–	–	﹤0.01%	117
2017 Q2	$10K	Hold	65	–	–	﹤0.01%	128
2017 Q1	$16K	Hold	65	–	–	﹤0.01%	129
2016 Q4	$18K	Hold	65	–	–	﹤0.01%	131
2016 Q3	$14K	Hold	65	–	–	﹤0.01%	129
2016 Q2	$25K	Hold	65	–	–	﹤0.01%	128
2016 Q1	$44K	Hold	65	–	–	﹤0.01%	123
2015 Q4	$68K	Hold	65	–	–	0.01%	121
2015 Q3	$56K	Hold	65	–	–	0.01%	117
2015 Q2	$46K	Hold	65	–	–	﹤0.01%	128
2015 Q1	$147K	Hold	65	–	–	0.01%	135
2014 Q4	$67K	Buy	+65	New	+$69.5K	0.01%	138

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Obermeyer Wealth Partners's AMPE Position: Q3 2019 in Review

Obermeyer Wealth Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2019, closing a stake of 65 shares — an estimated $8K sold.

Obermeyer Wealth Partners first reported a position in AMPE in Q4 2014 and held it in 19 quarters. The position peaked at $147K in Q1 2015. 75 funds tracked by Wall St. Rank hold AMPE as of Q3 2019.

Obermeyer Wealth Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2019 after selling out during the quarter.
Obermeyer Wealth Partners sold 65 Ampio Pharmaceuticals Inc. shares in Q3 2019, an estimated $8K.
Obermeyer Wealth Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2014 and held it in 19 quarters.
Obermeyer Wealth Partners's Ampio Pharmaceuticals Inc. position peaked at $147K in Q1 2015.
75 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2019.

Based on Obermeyer Wealth Partners's 13F filing for Q3 2019, filed 6 Nov 2019.